Sofiva Genomics Co.,Ltd. (TPEX:6615)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
33.10
+0.30 (0.91%)
Apr 29, 2026, 1:17 PM CST
-6.10%
Market Cap 714.74M
Revenue (ttm) 385.71M
Net Income (ttm) -9.36M
Shares Out 21.59M
EPS (ttm) -0.43
PE Ratio n/a
Forward PE n/a
Dividend 0.30 (0.89%)
Ex-Dividend Date Jun 27, 2025
Volume 28,821
Average Volume 30,768
Open 32.80
Previous Close 32.80
Day's Range 32.80 - 33.10
52-Week Range 28.90 - 37.05
Beta 0.27
RSI 42.97
Earnings Date May 15, 2026

About Sofiva Genomics

Sofiva Genomics Co.,Ltd. provides pre-pregnancy, prenatal, and newborn genetic testing and medical testing services in Taiwan and internationally. The company offers reproductive testing services, including preimplantation genetic testing for aneuploidy (PGT-A), non-invasive preimplantation genetic testing for aneuploidy (niPGT-A), and preimplantation genetic testing for monogenic diseases (PGT-M); and prenatal testing services, such as non-invasive prenatal screening, array, karyotyping, maternal serum screening for down syndrome, risk assessm... [Read more]

Sector Healthcare
Founded 2012
Employees 104
Stock Exchange Taipei Exchange
Ticker Symbol 6615
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.